Global Plant-based Cannabidiol (CBD) Nutraceuticals Market Size By Type (CBD Tinctures, Capsules And Softgels), By Application (Pharmacies, Retail Stores), By Region, And Segment Forecasts, 2023 to 20...

The Global Plant-based Cannabidiol (CBD) Nutraceuticals Market was valued at USD 6.4 billion in 2023 and is projected to reach USD 18.7 billion by 2031, expanding at a CAGR of 14.5% during the forecast period (2023–2031). The market is witnessing robust growth due to the increasing consumer shift toward plant-based health supplements, growing awareness of the therapeutic properties of CBD, and regulatory relaxations surrounding hemp-derived CBD products in several regions. These nutraceuticals—ranging from dietary supplements and functional foods to beverages—are rapidly gaining traction across demographics looking for natural wellness solutions, pain management, anxiety relief, and anti-inflammatory benefits.

Drivers:

1. Rising Demand for Natural and Plant-based Wellness Products

Consumers are increasingly opting for plant-based alternatives in their health regimens. The therapeutic potential of CBD—including its anti-inflammatory, anti-anxiety, and pain-relieving properties—is driving adoption across the nutraceuticals sector.

2. Regulatory Advancements and Legalization Trends

The gradual legalization of hemp-derived CBD products in countries like the U.S., Canada, Germany, and parts of Asia-Pacific is significantly easing barriers to market entry, creating favorable conditions for growth.

3. Expanding Consumer Base Across Age Groups

CBD nutraceuticals are gaining popularity among a wide age group—from millennials seeking holistic wellness to older adults managing chronic conditions—broadening the addressable market.

Restraints:

1. Regulatory Uncertainty in Some Regions

Despite growing acceptance, inconsistent global regulations, especially in parts of Asia and the Middle East, hinder full-scale international commercialization and supply chain fluidity.

2. Misinformation and Stigma

Persistent misconceptions linking CBD to psychoactive cannabis compounds limit wider adoption, particularly among conservative consumers or regulatory environments.

Opportunity:

1. Product Innovation and Diversification

Opportunities lie in the development of innovative formulations such as water-soluble CBD, functional snacks, and CBD-infused drinks, as well as targeted nutraceuticals for stress, sleep, and recovery.

2. Expansion in Emerging Markets

Markets in Latin America, Southeast Asia, and parts of Africa present untapped potential due to a rising middle class, increased health awareness, and gradual shifts in regulatory attitudes.

Market by System Type Insights:

Based on product type, the CBD Oil-based Nutraceuticals segment dominated the market in 2023. CBD oils are widely adopted due to their versatility and fast absorption properties. However, the CBD Gummies and Edibles segment is projected to grow at the fastest rate, fueled by their ease of consumption, palatability, and appeal to younger demographics.

Market by End-use Insights:

In 2023, the Wellness and General Health segment held the largest market share, driven by rising consumer focus on preventive healthcare. The Sports Nutrition and Recovery segment is also expected to exhibit substantial growth due to increasing use of CBD for muscle recovery and inflammation control among athletes and fitness enthusiasts.

Market by Regional Insights:

North America accounted for the highest revenue share in 2023, with the U.S. leading due to a favorable legal framework, high consumer awareness, and the presence of numerous market players. Europe follows closely, with significant traction in Germany and the UK. Asia-Pacific is expected to register the highest CAGR during the forecast period as regulatory frameworks evolve and awareness spreads.

Competitive Scenario:

Prominent players in the Global Plant-based CBD Nutraceuticals Market include Charlotte’s Web Holdings, Inc., CV Sciences, Inc., Medterra CBD, Inc., Elixinol Wellness Limited, Green Roads, and Endoca. These companies focus on product portfolio expansion, strategic partnerships, and increasing retail presence to gain competitive advantage.

Key Developments:

In 2023, Charlotte’s Web launched a new line of CBD-infused hydration beverages targeting wellness consumers.

In 2024, Medterra partnered with major pharmacies across Europe to expand distribution of its CBD capsules and tinctures.

In 2025, CV Sciences announced the launch of targeted CBD blends for cognitive support and sleep aid, driven by consumer demand.

Scope of Work – Global Plant-based Cannabidiol (CBD) Nutraceuticals Market

FAQs:

1) What is the current market size of the Global Plant-based Cannabidiol (CBD) Nutraceuticals Market?

The market was valued at USD 6.4 billion in 2023.

2) What is the major growth driver of the Global Plant-based Cannabidiol (CBD) Nutraceuticals Market?

The primary growth driver is the rising demand for natural, plant-based wellness products supported by increasing legal acceptance of CBD.

3) Which is the largest region during the forecast period in the Global Plant-based Cannabidiol (CBD) Nutraceuticals Market?

North America remains the dominant region due to early regulatory adoption and high consumer awareness.

4) Which segment accounted for the largest market share in Global Plant-based Cannabidiol (CBD) Nutraceuticals Market?

CBD Oil-based Nutraceuticals led the market by product type in 2023.

5) Who are the key market players in the Global Plant-based Cannabidiol (CBD) Nutraceuticals Market?

Key players include Charlotte’s Web Holdings, CV Sciences, Medterra, Elixinol Wellness, and Green Roads.